Du L - Search Results

1

microRNA regulation of cell viability and drug sensitivity in lung cancer.

Du L, Pertsemlidis A. Du L, et al. Expert Opin Biol Ther. 2012 Sep;12(9):1221-39. doi: 10.1517/14712598.2012.697149. Epub 2012 Jun 26. Expert Opin Biol Ther. 2012. PMID: 22731874 Review.

2

miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.

Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A. Du L, et al. Mol Cancer Res. 2009 Aug;7(8):1234-43. doi: 10.1158/1541-7786.MCR-08-0507. Epub 2009 Aug 11. Mol Cancer Res. 2009. PMID: 19671678 Free PMC article.

3

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.

Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM. Gibbons DL, et al. Among authors: du l. Genes Dev. 2009 Sep 15;23(18):2140-51. doi: 10.1101/gad.1820209. Genes Dev. 2009. PMID: 19759262 Free PMC article.

4

microRNAs and lung cancer: tumors and 22-mers.

Du L, Pertsemlidis A. Du L, et al. Cancer Metastasis Rev. 2010 Mar;29(1):109-22. doi: 10.1007/s10555-010-9204-9. Cancer Metastasis Rev. 2010. PMID: 20130964 Free PMC article. Review.

5

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.

Du L, Schageman JJ, Irnov, Girard L, Hammond SM, Minna JD, Gazdar AF, Pertsemlidis A. Du L, et al. J Exp Clin Cancer Res. 2010 Jun 17;29(1):75. doi: 10.1186/1756-9966-29-75. J Exp Clin Cancer Res. 2010. PMID: 20624269 Free PMC article.

6

Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.

Du L, Pertsemlidis A. Du L, et al. J Mol Cell Biol. 2011 Jun;3(3):176-80. doi: 10.1093/jmcb/mjq058. Epub 2011 Jan 28. J Mol Cell Biol. 2011. PMID: 21278200 Free PMC article. Review.

7

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers.

Du L, Subauste MC, DeSevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, Pertsemlidis A. Du L, et al. PLoS One. 2012;7(6):e39167. doi: 10.1371/journal.pone.0039167. Epub 2012 Jun 18. PLoS One. 2012. PMID: 22723956 Free PMC article.

8

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.

Du L, Zhao Z, Ma X, Hsiao TH, Chen Y, Young E, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A. Du L, et al. Oncogene. 2014 Aug 21;33(34):4307-15. doi: 10.1038/onc.2013.381. Epub 2013 Sep 16. Oncogene. 2014. PMID: 24037530 Free PMC article.

9

A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel.

Du L, Borkowski R, Zhao Z, Ma X, Yu X, Xie XJ, Pertsemlidis A. Du L, et al. RNA Biol. 2013 Nov;10(11):1700-13. doi: 10.4161/rna.26541. Epub 2013 Sep 30. RNA Biol. 2013. PMID: 24157646 Free PMC article.

10

A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation.

Zhao Z, Ma X, Hsiao TH, Lin G, Kosti A, Yu X, Suresh U, Chen Y, Tomlinson GE, Pertsemlidis A, Du L. Zhao Z, et al. Among authors: du l. Oncotarget. 2014 May 15;5(9):2499-512. doi: 10.18632/oncotarget.1703. Oncotarget. 2014. PMID: 24811707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,588 results

Search Page